AbbVie (ABBV) Dividend Coverage Ratio Growth (3y) (2016 - 2026)
Powered by 
Analysis
AbbVie (ABBV) Dividend Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 1.02% |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 15.11% |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 41.83% |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -27.98% |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.11% |
| Mar 31, 2026 | 101.62% |
| Dec 31, 2025 | -14.18% |
| Sep 30, 2025 | -65.54% |
| Jun 30, 2025 | -4.41% |
| Mar 31, 2025 | -37.19% |
| Dec 31, 2024 | -26.09% |
| Sep 30, 2024 | -25.48% |
| Jun 30, 2024 | 14.47% |
| Mar 31, 2024 | -31.37% |
| Dec 31, 2023 | 158.88% |
| Sep 30, 2023 | -14.94% |
| Jun 30, 2023 | 56.47% |
| Mar 31, 2023 | -26.44% |
| Dec 31, 2022 | -17.49% |
| Sep 30, 2022 | 10.05% |
| Jun 30, 2022 | -7.35% |
| Mar 31, 2022 | 4.77% |
| Dec 31, 2021 | 50.21% |
| Sep 30, 2021 | -9.94% |